Drug · DIN 02436736
CLÉO -35
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 4, 2018; first marketed October 30, 2015.
- Drug Identification Number (DIN)
- 02436736
- Company (DIN owner)
- Altius Healthcare IncMontmagny, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Cyproterone and estrogen G03HB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CYPROTERONE ACETATE | 2 MG | |
| ETHINYL ESTRADIOL | 0.035 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 20, 2017: NOC 19081Abbreviated New Drug Submission (ANDS) · Transfer of drug identification number
- January 27, 2015: NOC 16566Abbreviated New Drug Submission (ANDS)